Th2 responses to inactivated influenza virus can be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection

Journal of Infectious Diseases

Volumn 180, Issue 3, 1999, Pages 579-585

  Moran, Thomas M ^a   Park, Helen ^a   Fernandez Sesma, Ana ^a   Schulman, Jerome L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CYTOKINES; DOGS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TH2 CELLS; ULTRAVIOLET RAYS; VIRUS LATENCY;

EID: 0032822633     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314952     Document Type: Article

References (56)

1. 1. Zinkernagel RM. Immunology taught by viruses. Science 1996;271:173-8.
2. 2. Schulman JL, Kilbourne ED. Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus. J Bacteriology 1965;89:170-4.
3. 3. Topham DJ, Tripp CS, Hamilton-Easton SR, Sarawar SR, Doherty PC. Quantitative analysis of the influenza virus-specific CD4+ T cell memory in absence of B cells and Ig. J Immunol 1996;157:2947-52.
4. 4. Graham MB, Braciale TJ. Resistance to and Recovery from Lethal Influenza Virus Infection in B Lymphocyte-deficient Mice. J Exp Med 1997;186: 2063-8.
5. 5. Allan W, Tabi Z, Cleary A, Doherty PC. Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J Immunol 1990;144:3980-6.
6. 6. Doherty PC, Allan W, Eichelberger M, Carding SR. Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu Rev Immunol 1992;10: 123-51.
7. 7. Eichelberger M, Allan W, Zijlstra M, Jaenisch R, Doherty PC. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-resricted CD8+ T cells. J Exp Med 1991;174: 875-80.
8. 8. Scherle PA, Palladino G, Gerhard W. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J Immunol 1992;148:212-7.
9. 9. Spriggs MK, Killer BH, Sato T, et al. Beta 2-Microglobulin, CD8+ T-cell deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci USA 1992;89:6070-4.
10. 10. Topham DJ, Sarawar SR, Sangster MY, Doherty PC. Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/-respiratory epithelium. J Virol 1996;70:1288-91.
11. 11. Graham MB, Braciale VL, Braciale TJ. Influenza virus-specific CD4+ T helper type 2 T-lymphocytes do not promote recovery from experimental virus infection. J Exp Med 1994;180:1273-82.
12. 12. Cate TR, Mold NG. Increased influenza pneumonia mortality of mice adoptively immunized with node and spleen cells sensitized by inactivated but not live virus. Infection and Immunity 1975;11:908-14.
13. 13. Palladino G, Mozdzanowska K, Washko G, Gerhard W. Virus neutralizing antibodies of immunoglobulin G (IgG) but not IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol 1995;69:2075-81.
14. 14. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996;4:25-36.
15. 15. Abbas AK, Murphy K, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-93.
16. 16. Mosman T, Cherwinski H, Bond MW, Gredlin MA, Coffman RL. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
17. 17. Mossman TR, Sad S. The expanding universe of T cell subsets: TH1 and TH2 and more. Immunology Today 1996;17:138-47.
18. 18. Swain SL, Bradley LM, Croft M, et al. Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol Rev 1991;123:115-44.
19. 19. Moran TM, Isobe H, Fernandez-Sesma A, Schulman JL. IL-4 causes delayed virus clearance in influenza virus infected mice. J Virol 1996;70:5230-5.
20. 20. Fischer JE, Johnson JE, Kuli-zade RK, et al. Overexpression of IL-4 delays virus clearance in mice infected with respiratory syncytial virus. J Virol 1997;71:8672-7.
21. 21. Actor JK, Shirai M, Kullberg MC, Buller RM, Sher A, Bersofsky JA. Helminth infection results in decreased virus-specific CD8+ cytotoxic T cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci USA 1993;90:948-52.
22. 22. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76: 241-51.
23. 23. Ohshima Y, Delespesse G. T cell derived IL-4 and dendritic cell derived IL-12 regulate the lymphokine producing phenotype of alloantigen primed naive human CD4 T cells. J Immunol 1997;158:629-36.
24. 24. Hsieh CS, Macatonia SE, Tripp CS, Wolf S, O'Garra A, Murphy K. Development of Th1 CD4+ T cells through IL-12 produced by listeriainduced macrophages. Science 1993;260:547-9.
25. 25. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK. Recombinant Interleukin 12 cures mice infected with Leishmania major. J Exp Med 1993;177:1505-9.
26. 26. Heufler C, Koch F, Stanzl U, et al. Interleukin 12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-production by T helper 1 cells . Eur J Immunol 1996;26:659-68.
27. 27. Macatonia SE, Hosken S, Litton M, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4 T cells. J Immunol 1995;154:5071-5076.
28. 28. O'Garra A, Hosken S, Macatonia SE, Wenner CA, Murphy K. The role of macrophages and dendritic cell derived IL12 in Th1 phenotype development. Res Immunol 1995;146:466-72.
29. 29. Seder RA, Paul WE. Acquisition of lymphokine producing phenotype by CD4 T cells. Annu Rev Immunol 1994;12:635-7.
30. 30. Liang S, Mozdzanowska K, Palladino G, Gerhard W. Heterosubtypic Immunity to influenza type A virus in mice. J Immunol 1994;152:1653-61.
31. 31. Kilbourne ED. Influenza. New York & London: Plenum Press, 1987.
32. 32. Yewdell J, Hackett CJ. The Specificity and function of T lymphocytes induced by influenza A viruses. In: Krug RM, ed. The Influenza Viruses. New York, NY: Plenum Publishing Corp. 1989:361.
33. 33. Lukacher AE, Braciale VL, Braciale TJ. In vivo effector function of influenza virus specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 1984;160:814-26.
34. 34. Lightman S, Cobbold S, Waldmann H, Askonas BA. Do L3T4+ T cells act as effectors in protection against influenza virus infection? Immunology 1987;62:139-44.
35. 35. Taylor PM, Askonas BA. Influenza nucleoprotein specific cytotoxic T-cell clones are protective in vivo. Immunology 1986;58:417-20.
36. 36. Endo A, Itamura S, Iinuma S, Funahashi S, Shida H, Koide F, Nerome K, Oya A. Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the hemagglutinin or nucleoprotein gene of influenza virus. J Gen Virol 1991;72: 699-703.
37. 37. Ulmer JB, Donnelly JJ, Parker SE, et al. Heterologous protection against influenza virus by injection of DNA encoding a viral protein. Science 1993;259:1745-9.
38. 38. Armerding D, Rossiter H, Ghazzouli I, Liehl E. Evaluation of live and inactivated influenza A virus vaccines in a mouse model. J Infect Dis 1982;145:320-30.
39. 39. Leung KN, Ada GL. Different functions of effector T cells in murine influenza virus infection. Cellular Immunology 1982;67:312-24.
40. 40. Graham BS, Henderson GS, Tang YW, Liu X, Neuzil KM, Colley DG. Primary immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 1993;151:2032-40.
41. 41. Waris ME, Tsou C, Erdman DD, Zaki SR, Anderson L. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-in-activated virus induces enhanced pulmonary inflammatory response with a predominantly Th2 like cytokine pattern. J Virol 1996;70:2852-60.
42. 42. Tang Y, Graham BS. Interleukin-12 treatment during immunization elicits a T helper cell type 1 like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. J Infect Dis 1995;172:734-8.
43. 43. Moran TM, Usuba O, Kuzu H, Kuzu Y, Schulman, Bona CA. Inhibition of multicycle virus replication by hybrid antibodies and cytotoxic T lymphocytes. J Immunol 1991;146:321-6.
44. 44. Schulman JL, Kilbourne ED. Use of an animal model to study transmission of influenza virus Infection. Am J Public Health Nations Health 1968; 58:2092-6.
45. 45. Bender A, Bui LK, Feldman MAV, Larsson M, Bhardwaj N. Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J Exp Med 1995;182:1663-71.
46. 46. Liew FY, Russell SM. Inhibition of pathogenic effects of effector cells by-specific suppressor cells during influenza virus infection in mice. Nature 1983;304:541-3.
47. 47. Bender BS, Croghan.T, Zhang L, Small PA. Transgenic mice lacking class 1 major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 1992;175:1143-5.
48. 48. Coutelier JP, Van Broeck J, Wolf S. Interleukin 12 gene expression after viral infection in the mouse. J Virol 1995;69:1955-8.
49. 49. Orange JS, Biron C. Characterization of early IL-12, INF, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol 1996;156:4746-56.
50. 50. Kanangat S, Thomas J, Gangappa S, Babu S, Rouse B. Herpes simples virus type 1 mediated up-regulation of IL-12 mRNA expression . Implication in immunopathogenesis and protection. J Immunol 1996;156:1110-6.
51. 51. Fugier-Vivier C, Servet-Delprat P, Rivaller P, Rissoan M-C, Liu Y-J, Rabourdin-Combe C. Measles virus suppresses cell mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 1997;186:813-24.
52. 52. Bot A, Casares S, Bot S, von Boehmer H, Bona CA. Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR receptor specific for class II hemagglutinin peptide in CD4 and CD8 T cells. J Immunol 1998;160:4500-7.
53. 53. Banchereau J, Steinman RM. Dendritic Cells and the Control of Immunity. Nature 1998;392:245-52.
54. 54. Reis e Sousa CS, Hieny T, Scharton-Kersten D, et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med 1997;186:1819-29.
55. 55. Winzler C, Rovere P, Rescigno M, et al. Maturation stages of mouse dendritic cells in growth factor dependent long-term cultures. J Exp Med 1997;185: 317-28.
56. 56. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-18.